APO Research
Talk to an analyst

APO RESEARCH · REPORT

Defibrinated Animal Blood

Compare research editions
View pricing & licenses

Selected research

Industry Research

Defibrinated Animal Blood Industry Research Report 2026

8 January 2026148 pages

Choose your research edition.

Industry ResearchDefibrinated Animal Blood Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Defibrinated Animal Blood Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Defibrinated Animal Blood Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Defibrinated Animal Blood Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Defibrinated Animal Blood Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Defibrinated Animal Blood market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Defibrinated Animal Blood is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Defibrinated Animal Blood is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Defibrinated Animal Blood is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Defibrinated Animal Blood include Thermo Fisher Scientific, TCS Biosciences, BioMérieux, E & O Laboratories Ltd, Southern Biological, Trafalgar Scientific, HemoStat Laboratories, Dutscher and Serana Europe, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Defibrinated Animal Blood market in terms of revenue (US$ million) and, where applicable, sales volume (kL), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/kL) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Defibrinated Animal Blood Market by Company

Thermo Fisher Scientific

TCS Biosciences

BioMérieux

E & O Laboratories Ltd

Southern Biological

Trafalgar Scientific

HemoStat Laboratories

Dutscher

Serana Europe

Innovative Research Inc

Colorado Serum

SSI Diagnostica

SR Group

Szabo-Scandic

Rockland Immunochemicals, Inc.

LABone Scientific Co.Ltd.

Biowest(BioNordic A/S)

Pel-Freez Biologicals

EWC Diagnostics

Kraeber & Co. GmbH

Bio Nutrientes Do Brasil Ltda.

Lampire Biological Laboratories, Inc.

Quad Five(Materials Bio Inc.)

Guangzhou Ruite Biotechnology Co., Ltd.

Obio Technology (Shanghai) Corp., Ltd.

Beijing Solarbio Science & Technology Co.,Ltd.

Nanjing SenBeiJia Biological Technology Co., Ltd.

Changde BKMAM Biotechnology Co. Ltd.

Beijing Baiao Leibo Technology Co., Ltd.

Defibrinated Animal Blood Segment by Type

Bovine

Horse

Rabbit

Sheep

Others

Defibrinated Animal Blood Segment by Application

Biomedicine

Research

Defibrinated Animal Blood Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Defibrinated Animal Blood market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Defibrinated Animal Blood and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Defibrinated Animal Blood.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Defibrinated Animal Blood manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Defibrinated Animal Blood by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Defibrinated Animal Blood in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Defibrinated Animal Blood Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Defibrinated Animal Blood Sales (kL) of Manufacturers (2021-2026) Table 7. Global Defibrinated Animal Blood Sales Market Share by Manufacturers (2021-2026) Table 8. Global Defibrinated Animal Blood Revenue of Manufacturers (2021-2026) Table 9. Global Defibrinated Animal Blood Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Defibrinated Animal Blood Average Price (USD/L) of Manufacturers (2021-2026) Table 11. Global Defibrinated Animal Blood Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Defibrinated Animal Blood, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Defibrinated Animal Blood, Product Type & Application Table 14. Global Defibrinated Animal Blood Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Defibrinated Animal Blood by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Thermo Fisher Scientific Company Information Table 19. Thermo Fisher Scientific Business Overview Table 20. Thermo Fisher Scientific Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 21. Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio Table 22. Thermo Fisher Scientific Recent Developments Table 23. TCS Biosciences Company Information Table 24. TCS Biosciences Business Overview Table 25. TCS Biosciences Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 26. TCS Biosciences Defibrinated Animal Blood Product Portfolio Table 27. TCS Biosciences Recent Developments Table 28. BioMérieux Company Information Table 29. BioMérieux Business Overview Table 30. BioMérieux Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 31. BioMérieux Defibrinated Animal Blood Product Portfolio Table 32. BioMérieux Recent Developments Table 33. E & O Laboratories Ltd Company Information Table 34. E & O Laboratories Ltd Business Overview Table 35. E & O Laboratories Ltd Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 36. E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio Table 37. E & O Laboratories Ltd Recent Developments Table 38. Southern Biological Company Information Table 39. Southern Biological Business Overview Table 40. Southern Biological Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 41. Southern Biological Defibrinated Animal Blood Product Portfolio Table 42. Southern Biological Recent Developments Table 43. Trafalgar Scientific Company Information Table 44. Trafalgar Scientific Business Overview Table 45. Trafalgar Scientific Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 46. Trafalgar Scientific Defibrinated Animal Blood Product Portfolio Table 47. Trafalgar Scientific Recent Developments Table 48. HemoStat Laboratories Company Information Table 49. HemoStat Laboratories Business Overview Table 50. HemoStat Laboratories Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 51. HemoStat Laboratories Defibrinated Animal Blood Product Portfolio Table 52. HemoStat Laboratories Recent Developments Table 53. Dutscher Company Information Table 54. Dutscher Business Overview Table 55. Dutscher Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 56. Dutscher Defibrinated Animal Blood Product Portfolio Table 57. Dutscher Recent Developments Table 58. Serana Europe Company Information Table 59. Serana Europe Business Overview Table 60. Serana Europe Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 61. Serana Europe Defibrinated Animal Blood Product Portfolio Table 62. Serana Europe Recent Developments Table 63. Innovative Research Inc Company Information Table 64. Innovative Research Inc Business Overview Table 65. Innovative Research Inc Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 66. Innovative Research Inc Defibrinated Animal Blood Product Portfolio Table 67. Innovative Research Inc Recent Developments Table 68. Colorado Serum Company Information Table 69. Colorado Serum Business Overview Table 70. Colorado Serum Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 71. Colorado Serum Defibrinated Animal Blood Product Portfolio Table 72. Colorado Serum Recent Developments Table 73. SSI Diagnostica Company Information Table 74. SSI Diagnostica Business Overview Table 75. SSI Diagnostica Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 76. SSI Diagnostica Defibrinated Animal Blood Product Portfolio Table 77. SSI Diagnostica Recent Developments Table 78. SR Group Company Information Table 79. SR Group Business Overview Table 80. SR Group Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 81. SR Group Defibrinated Animal Blood Product Portfolio Table 82. SR Group Recent Developments Table 83. Szabo-Scandic Company Information Table 84. Szabo-Scandic Business Overview Table 85. Szabo-Scandic Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 86. Szabo-Scandic Defibrinated Animal Blood Product Portfolio Table 87. Szabo-Scandic Recent Developments Table 88. Rockland Immunochemicals, Inc. Company Information Table 89. Rockland Immunochemicals, Inc. Business Overview Table 90. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 91. Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio Table 92. Rockland Immunochemicals, Inc. Recent Developments Table 93. LABone Scientific Co.Ltd. Company Information Table 94. LABone Scientific Co.Ltd. Business Overview Table 95. LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 96. LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio Table 97. LABone Scientific Co.Ltd. Recent Developments Table 98. Biowest(BioNordic A/S) Company Information Table 99. Biowest(BioNordic A/S) Business Overview Table 100. Biowest(BioNordic A/S) Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 101. Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio Table 102. Biowest(BioNordic A/S) Recent Developments Table 103. Pel-Freez Biologicals Company Information Table 104. Pel-Freez Biologicals Business Overview Table 105. Pel-Freez Biologicals Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 106. Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio Table 107. Pel-Freez Biologicals Recent Developments Table 108. EWC Diagnostics Company Information Table 109. EWC Diagnostics Business Overview Table 110. EWC Diagnostics Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 111. EWC Diagnostics Defibrinated Animal Blood Product Portfolio Table 112. EWC Diagnostics Recent Developments Table 113. Kraeber & Co. GmbH Company Information Table 114. Kraeber & Co. GmbH Business Overview Table 115. Kraeber & Co. GmbH Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 116. Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio Table 117. Kraeber & Co. GmbH Recent Developments Table 118. Bio Nutrientes Do Brasil Ltda. Company Information Table 119. Bio Nutrientes Do Brasil Ltda. Business Overview Table 120. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 121. Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio Table 122. Bio Nutrientes Do Brasil Ltda. Recent Developments Table 123. Lampire Biological Laboratories, Inc. Company Information Table 124. Lampire Biological Laboratories, Inc. Business Overview Table 125. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 126. Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio Table 127. Lampire Biological Laboratories, Inc. Recent Developments Table 128. Quad Five(Materials Bio Inc.) Company Information Table 129. Quad Five(Materials Bio Inc.) Business Overview Table 130. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 131. Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio Table 132. Quad Five(Materials Bio Inc.) Recent Developments Table 133. Guangzhou Ruite Biotechnology Co., Ltd. Company Information Table 134. Guangzhou Ruite Biotechnology Co., Ltd. Business Overview Table 135. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 136. Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 137. Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments Table 138. Obio Technology (Shanghai) Corp., Ltd. Company Information Table 139. Obio Technology (Shanghai) Corp., Ltd. Business Overview Table 140. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 141. Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio Table 142. Obio Technology (Shanghai) Corp., Ltd. Recent Developments Table 143. Beijing Solarbio Science & Technology Co.,Ltd. Company Information Table 144. Beijing Solarbio Science & Technology Co.,Ltd. Business Overview Table 145. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 146. Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio Table 147. Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments Table 148. Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information Table 149. Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview Table 150. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 151. Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 152. Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments Table 153. Changde BKMAM Biotechnology Co. Ltd. Company Information Table 154. Changde BKMAM Biotechnology Co. Ltd. Business Overview Table 155. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 156. Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio Table 157. Changde BKMAM Biotechnology Co. Ltd. Recent Developments Table 158. Beijing Baiao Leibo Technology Co., Ltd. Company Information Table 159. Beijing Baiao Leibo Technology Co., Ltd. Business Overview Table 160. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales (kL), Revenue (US$ Million), Price (USD/L) and Gross Margin (2021-2026) Table 161. Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio Table 162. Beijing Baiao Leibo Technology Co., Ltd. Recent Developments Table 163. Global Defibrinated Animal Blood Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 164. Global Defibrinated Animal Blood Sales by Region (2021-2026) & (kL) Table 165. Global Defibrinated Animal Blood Sales Market Share by Region (2021-2026) Table 166. Global Defibrinated Animal Blood Sales by Region (2027-2032) & (kL) Table 167. Global Defibrinated Animal Blood Sales Market Share by Region (2027-2032) Table 168. Global Defibrinated Animal Blood Revenue by Region (2021-2026) & (US$ Million) Table 169. Global Defibrinated Animal Blood Revenue Market Share by Region (2021-2026) Table 170. Global Defibrinated Animal Blood Revenue by Region (2027-2032) & (US$ Million) Table 171. Global Defibrinated Animal Blood Revenue Market Share by Region (2027-2032) Table 172. North America Defibrinated Animal Blood Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 173. North America Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 174. North America Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 175. North America Defibrinated Animal Blood Revenue by Country (2021-2026) & (US$ Million) Table 176. North America Defibrinated Animal Blood Revenue by Country (2027-2032) & (US$ Million) Table 177. Europe Defibrinated Animal Blood Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 178. Europe Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 179. Europe Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 180. Europe Defibrinated Animal Blood Revenue by Country (2021-2026) & (US$ Million) Table 181. Europe Defibrinated Animal Blood Revenue by Country (2027-2032) & (US$ Million) Table 182. Asia Pacific Defibrinated Animal Blood Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 183. Asia Pacific Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 184. Asia Pacific Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 185. Asia Pacific Defibrinated Animal Blood Revenue by Country (2021-2026) & (US$ Million) Table 186. Asia Pacific Defibrinated Animal Blood Revenue by Country (2027-2032) & (US$ Million) Table 187. South America Defibrinated Animal Blood Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 188. South America Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 189. South America Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 190. South America Defibrinated Animal Blood Revenue by Country (2021-2026) & (US$ Million) Table 191. South America Defibrinated Animal Blood Revenue by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Defibrinated Animal Blood Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 193. Middle East and Africa Defibrinated Animal Blood Sales by Country (2021-2026) & (kL) Table 194. Middle East and Africa Defibrinated Animal Blood Sales by Country (2027-2032) & (kL) Table 195. Middle East and Africa Defibrinated Animal Blood Revenue by Country (2021-2026) & (US$ Million) Table 196. Middle East and Africa Defibrinated Animal Blood Revenue by Country (2027-2032) & (US$ Million) Table 197. Global Defibrinated Animal Blood Sales by Type (2021-2026) & (kL) Table 198. Global Defibrinated Animal Blood Sales by Type (2027-2032) & (kL) Table 199. Global Defibrinated Animal Blood Sales Market Share by Type (2021-2026) Table 200. Global Defibrinated Animal Blood Sales Market Share by Type (2027-2032) Table 201. Global Defibrinated Animal Blood Revenue by Type (2021-2026) & (US$ Million) Table 202. Global Defibrinated Animal Blood Revenue by Type (2027-2032) & (US$ Million) Table 203. Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2026) Table 204. Global Defibrinated Animal Blood Revenue Market Share by Type (2027-2032) Table 205. Global Defibrinated Animal Blood Price by Type (2021-2026) & (USD/L) Table 206. Global Defibrinated Animal Blood Price by Type (2027-2032) & (USD/L) Table 207. Global Defibrinated Animal Blood Sales by Application (2021-2026) & (kL) Table 208. Global Defibrinated Animal Blood Sales by Application (2027-2032) & (kL) Table 209. Global Defibrinated Animal Blood Sales Market Share by Application (2021-2026) Table 210. Global Defibrinated Animal Blood Sales Market Share by Application (2027-2032) Table 211. Global Defibrinated Animal Blood Revenue by Application (2021-2026) & (US$ Million) Table 212. Global Defibrinated Animal Blood Revenue by Application (2027-2032) & (US$ Million) Table 213. Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2026) Table 214. Global Defibrinated Animal Blood Revenue Market Share by Application (2027-2032) Table 215. Global Defibrinated Animal Blood Price by Application (2021-2026) & (USD/L) Table 216. Global Defibrinated Animal Blood Price by Application (2027-2032) & (USD/L) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Defibrinated Animal Blood Distributors List Table 220. Defibrinated Animal Blood Customers List Table 221. Defibrinated Animal Blood Industry Trends Table 222. Defibrinated Animal Blood Industry Drivers Table 223. Defibrinated Animal Blood Industry Restraints Table 224. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Defibrinated Animal Blood Product Image Figure 5. Global Defibrinated Animal Blood Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Defibrinated Animal Blood Market Size (2021-2032) & (US$ Million) Figure 7. Global Defibrinated Animal Blood Sales (2021-2032) & (kL) Figure 8. Global Defibrinated Animal Blood Average Price (USD/L) & (2021-2032) Figure 9. Bovine Product Image Figure 10. Horse Product Image Figure 11. Rabbit Product Image Figure 12. Sheep Product Image Figure 13. Others Product Image Figure 14. Biomedicine Product Image Figure 15. Research Product Image Figure 16. Global Defibrinated Animal Blood Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Defibrinated Animal Blood, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Defibrinated Animal Blood Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Defibrinated Animal Blood Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Defibrinated Animal Blood Sales by Region in 2025 Figure 22. Global Defibrinated Animal Blood Revenue by Region in 2025 Figure 23. North America Defibrinated Animal Blood Market Size by Country in 2025 Figure 24. North America Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 25. North America Defibrinated Animal Blood Revenue Market Share by Country (2021-2032) Figure 26. United States Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Defibrinated Animal Blood Market Size by Country in 2025 Figure 30. Europe Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 31. Europe Defibrinated Animal Blood Revenue Market Share by Country (2021-2032) Figure 32. Germany Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Defibrinated Animal Blood Market Size by Country in 2025 Figure 43. Asia Pacific Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Defibrinated Animal Blood Revenue Market Share by Country (2021-2032) Figure 45. China Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Defibrinated Animal Blood Market Size by Country in 2025 Figure 54. South America Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 55. South America Defibrinated Animal Blood Revenue Market Share by Country (2021-2032) Figure 56. Brazil Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Colombia Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Middle East and Africa Defibrinated Animal Blood Market Size by Country in 2025 Figure 61. Middle East and Africa Defibrinated Animal Blood Sales Market Share by Country (2021-2032) Figure 62. Middle East and Africa Defibrinated Animal Blood Revenue Market Share by Country (2021-2032) Figure 63. Egypt Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. South Africa Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Israel Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Türkiye Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. GCC Countries Defibrinated Animal Blood Revenue Growth Rate (2021-2032) & (US$ Million) Figure 68. Global Defibrinated Animal Blood Sales Market Share by Type (2021-2032) Figure 69. Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2032) Figure 70. Global Defibrinated Animal Blood Price (USD/L) by Type (2021-2032) Figure 71. Global Defibrinated Animal Blood Sales Market Share by Application (2021-2032) Figure 72. Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2032) Figure 73. Global Defibrinated Animal Blood Price (USD/L) by Application (2021-2032) Figure 74. Defibrinated Animal Blood Value Chain Figure 75. Defibrinated Animal Blood Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Defibrinated Animal Blood Industry Opportunities and Challenges

Scope & coverage.

Types
  • Bovine
  • Horse
  • Rabbit
  • Sheep
  • Others
Applications
  • Biomedicine
  • Research
Companies covered
  • Thermo Fisher Scientific
  • TCS Biosciences
  • BioMérieux
  • E & O Laboratories Ltd
  • Southern Biological
  • Trafalgar Scientific
  • HemoStat Laboratories
  • Dutscher
  • Serana Europe
  • Innovative Research Inc
  • Colorado Serum
  • SSI Diagnostica
  • SR Group
  • Szabo-Scandic
  • Rockland Immunochemicals, Inc.
  • LABone Scientific Co.Ltd.
  • Biowest(BioNordic A/S)
  • Pel-Freez Biologicals
  • EWC Diagnostics
  • Kraeber & Co. GmbH
  • Bio Nutrientes Do Brasil Ltda.
  • Lampire Biological Laboratories, Inc.
  • Quad Five(Materials Bio Inc.)
  • Guangzhou Ruite Biotechnology Co., Ltd.
  • Obio Technology (Shanghai) Corp., Ltd.
  • Beijing Solarbio Science & Technology Co.,Ltd.
  • Nanjing SenBeiJia Biological Technology Co., Ltd.
  • Changde BKMAM Biotechnology Co. Ltd.
  • Beijing Baiao Leibo Technology Co., Ltd.

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Defibrinated Animal Blood Market Size (2021-2032)
  4. 2.2.2 Global Defibrinated Animal Blood Sales (2021-2032)
  5. 2.2.3 Global Defibrinated Animal Blood Market Average Price (2021-2032)
  6. 2.3 Defibrinated Animal Blood by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Bovine
  9. 2.3.3 Horse
  10. 2.3.4 Rabbit
  11. 2.3.5 Sheep
  12. 2.3.6 Others
  13. 2.4 Defibrinated Animal Blood by Application
  14. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  15. 2.4.2 Biomedicine
  16. 2.4.3 Research
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Defibrinated Animal Blood Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Defibrinated Animal Blood Sales (kL) of Manufacturers (2021-2026)
  3. 3.3 Global Defibrinated Animal Blood Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Defibrinated Animal Blood Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Defibrinated Animal Blood Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Defibrinated Animal Blood, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Defibrinated Animal Blood, Product Type & Application
  8. 3.8 Global Manufacturers of Defibrinated Animal Blood, Established Date
  9. 3.9 Global Defibrinated Animal Blood Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Thermo Fisher Scientific
  2. 4.1.1 Thermo Fisher Scientific Company Information
  3. 4.1.2 Thermo Fisher Scientific Business Overview
  4. 4.1.3 Thermo Fisher Scientific Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Thermo Fisher Scientific Defibrinated Animal Blood Product Portfolio
  6. 4.1.5 Thermo Fisher Scientific Recent Developments
  7. 4.2 TCS Biosciences
  8. 4.2.1 TCS Biosciences Company Information
  9. 4.2.2 TCS Biosciences Business Overview
  10. 4.2.3 TCS Biosciences Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 TCS Biosciences Defibrinated Animal Blood Product Portfolio
  12. 4.2.5 TCS Biosciences Recent Developments
  13. 4.3 BioMérieux
  14. 4.3.1 BioMérieux Company Information
  15. 4.3.2 BioMérieux Business Overview
  16. 4.3.3 BioMérieux Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 BioMérieux Defibrinated Animal Blood Product Portfolio
  18. 4.3.5 BioMérieux Recent Developments
  19. 4.4 E & O Laboratories Ltd
  20. 4.4.1 E & O Laboratories Ltd Company Information
  21. 4.4.2 E & O Laboratories Ltd Business Overview
  22. 4.4.3 E & O Laboratories Ltd Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 E & O Laboratories Ltd Defibrinated Animal Blood Product Portfolio
  24. 4.4.5 E & O Laboratories Ltd Recent Developments
  25. 4.5 Southern Biological
  26. 4.5.1 Southern Biological Company Information
  27. 4.5.2 Southern Biological Business Overview
  28. 4.5.3 Southern Biological Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Southern Biological Defibrinated Animal Blood Product Portfolio
  30. 4.5.5 Southern Biological Recent Developments
  31. 4.6 Trafalgar Scientific
  32. 4.6.1 Trafalgar Scientific Company Information
  33. 4.6.2 Trafalgar Scientific Business Overview
  34. 4.6.3 Trafalgar Scientific Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Trafalgar Scientific Defibrinated Animal Blood Product Portfolio
  36. 4.6.5 Trafalgar Scientific Recent Developments
  37. 4.7 HemoStat Laboratories
  38. 4.7.1 HemoStat Laboratories Company Information
  39. 4.7.2 HemoStat Laboratories Business Overview
  40. 4.7.3 HemoStat Laboratories Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 HemoStat Laboratories Defibrinated Animal Blood Product Portfolio
  42. 4.7.5 HemoStat Laboratories Recent Developments
  43. 4.8 Dutscher
  44. 4.8.1 Dutscher Company Information
  45. 4.8.2 Dutscher Business Overview
  46. 4.8.3 Dutscher Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Dutscher Defibrinated Animal Blood Product Portfolio
  48. 4.8.5 Dutscher Recent Developments
  49. 4.9 Serana Europe
  50. 4.9.1 Serana Europe Company Information
  51. 4.9.2 Serana Europe Business Overview
  52. 4.9.3 Serana Europe Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Serana Europe Defibrinated Animal Blood Product Portfolio
  54. 4.9.5 Serana Europe Recent Developments
  55. 4.10 Innovative Research Inc
  56. 4.10.1 Innovative Research Inc Company Information
  57. 4.10.2 Innovative Research Inc Business Overview
  58. 4.10.3 Innovative Research Inc Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Innovative Research Inc Defibrinated Animal Blood Product Portfolio
  60. 4.10.5 Innovative Research Inc Recent Developments
  61. 4.11 Colorado Serum
  62. 4.11.1 Colorado Serum Company Information
  63. 4.11.2 Colorado Serum Business Overview
  64. 4.11.3 Colorado Serum Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Colorado Serum Defibrinated Animal Blood Product Portfolio
  66. 4.11.5 Colorado Serum Recent Developments
  67. 4.12 SSI Diagnostica
  68. 4.12.1 SSI Diagnostica Company Information
  69. 4.12.2 SSI Diagnostica Business Overview
  70. 4.12.3 SSI Diagnostica Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 SSI Diagnostica Defibrinated Animal Blood Product Portfolio
  72. 4.12.5 SSI Diagnostica Recent Developments
  73. 4.13 SR Group
  74. 4.13.1 SR Group Company Information
  75. 4.13.2 SR Group Business Overview
  76. 4.13.3 SR Group Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 SR Group Defibrinated Animal Blood Product Portfolio
  78. 4.13.5 SR Group Recent Developments
  79. 4.14 Szabo-Scandic
  80. 4.14.1 Szabo-Scandic Company Information
  81. 4.14.2 Szabo-Scandic Business Overview
  82. 4.14.3 Szabo-Scandic Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Szabo-Scandic Defibrinated Animal Blood Product Portfolio
  84. 4.14.5 Szabo-Scandic Recent Developments
  85. 4.15 Rockland Immunochemicals, Inc.
  86. 4.15.1 Rockland Immunochemicals, Inc. Company Information
  87. 4.15.2 Rockland Immunochemicals, Inc. Business Overview
  88. 4.15.3 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Rockland Immunochemicals, Inc. Defibrinated Animal Blood Product Portfolio
  90. 4.15.5 Rockland Immunochemicals, Inc. Recent Developments
  91. 4.16 LABone Scientific Co.Ltd.
  92. 4.16.1 LABone Scientific Co.Ltd. Company Information
  93. 4.16.2 LABone Scientific Co.Ltd. Business Overview
  94. 4.16.3 LABone Scientific Co.Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 LABone Scientific Co.Ltd. Defibrinated Animal Blood Product Portfolio
  96. 4.16.5 LABone Scientific Co.Ltd. Recent Developments
  97. 4.17 Biowest(BioNordic A/S)
  98. 4.17.1 Biowest(BioNordic A/S) Company Information
  99. 4.17.2 Biowest(BioNordic A/S) Business Overview
  100. 4.17.3 Biowest(BioNordic A/S) Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Biowest(BioNordic A/S) Defibrinated Animal Blood Product Portfolio
  102. 4.17.5 Biowest(BioNordic A/S) Recent Developments
  103. 4.18 Pel-Freez Biologicals
  104. 4.18.1 Pel-Freez Biologicals Company Information
  105. 4.18.2 Pel-Freez Biologicals Business Overview
  106. 4.18.3 Pel-Freez Biologicals Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Pel-Freez Biologicals Defibrinated Animal Blood Product Portfolio
  108. 4.18.5 Pel-Freez Biologicals Recent Developments
  109. 4.19 EWC Diagnostics
  110. 4.19.1 EWC Diagnostics Company Information
  111. 4.19.2 EWC Diagnostics Business Overview
  112. 4.19.3 EWC Diagnostics Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 EWC Diagnostics Defibrinated Animal Blood Product Portfolio
  114. 4.19.5 EWC Diagnostics Recent Developments
  115. 4.20 Kraeber & Co. GmbH
  116. 4.20.1 Kraeber & Co. GmbH Company Information
  117. 4.20.2 Kraeber & Co. GmbH Business Overview
  118. 4.20.3 Kraeber & Co. GmbH Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Kraeber & Co. GmbH Defibrinated Animal Blood Product Portfolio
  120. 4.20.5 Kraeber & Co. GmbH Recent Developments
  121. 4.21 Bio Nutrientes Do Brasil Ltda.
  122. 4.21.1 Bio Nutrientes Do Brasil Ltda. Company Information
  123. 4.21.2 Bio Nutrientes Do Brasil Ltda. Business Overview
  124. 4.21.3 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Bio Nutrientes Do Brasil Ltda. Defibrinated Animal Blood Product Portfolio
  126. 4.21.5 Bio Nutrientes Do Brasil Ltda. Recent Developments
  127. 4.22 Lampire Biological Laboratories, Inc.
  128. 4.22.1 Lampire Biological Laboratories, Inc. Company Information
  129. 4.22.2 Lampire Biological Laboratories, Inc. Business Overview
  130. 4.22.3 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Lampire Biological Laboratories, Inc. Defibrinated Animal Blood Product Portfolio
  132. 4.22.5 Lampire Biological Laboratories, Inc. Recent Developments
  133. 4.23 Quad Five(Materials Bio Inc.)
  134. 4.23.1 Quad Five(Materials Bio Inc.) Company Information
  135. 4.23.2 Quad Five(Materials Bio Inc.) Business Overview
  136. 4.23.3 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  137. 4.23.4 Quad Five(Materials Bio Inc.) Defibrinated Animal Blood Product Portfolio
  138. 4.23.5 Quad Five(Materials Bio Inc.) Recent Developments
  139. 4.24 Guangzhou Ruite Biotechnology Co., Ltd.
  140. 4.24.1 Guangzhou Ruite Biotechnology Co., Ltd. Company Information
  141. 4.24.2 Guangzhou Ruite Biotechnology Co., Ltd. Business Overview
  142. 4.24.3 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  143. 4.24.4 Guangzhou Ruite Biotechnology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  144. 4.24.5 Guangzhou Ruite Biotechnology Co., Ltd. Recent Developments
  145. 4.25 Obio Technology (Shanghai) Corp., Ltd.
  146. 4.25.1 Obio Technology (Shanghai) Corp., Ltd. Company Information
  147. 4.25.2 Obio Technology (Shanghai) Corp., Ltd. Business Overview
  148. 4.25.3 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  149. 4.25.4 Obio Technology (Shanghai) Corp., Ltd. Defibrinated Animal Blood Product Portfolio
  150. 4.25.5 Obio Technology (Shanghai) Corp., Ltd. Recent Developments
  151. 4.26 Beijing Solarbio Science & Technology Co.,Ltd.
  152. 4.26.1 Beijing Solarbio Science & Technology Co.,Ltd. Company Information
  153. 4.26.2 Beijing Solarbio Science & Technology Co.,Ltd. Business Overview
  154. 4.26.3 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  155. 4.26.4 Beijing Solarbio Science & Technology Co.,Ltd. Defibrinated Animal Blood Product Portfolio
  156. 4.26.5 Beijing Solarbio Science & Technology Co.,Ltd. Recent Developments
  157. 4.27 Nanjing SenBeiJia Biological Technology Co., Ltd.
  158. 4.27.1 Nanjing SenBeiJia Biological Technology Co., Ltd. Company Information
  159. 4.27.2 Nanjing SenBeiJia Biological Technology Co., Ltd. Business Overview
  160. 4.27.3 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  161. 4.27.4 Nanjing SenBeiJia Biological Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  162. 4.27.5 Nanjing SenBeiJia Biological Technology Co., Ltd. Recent Developments
  163. 4.28 Changde BKMAM Biotechnology Co. Ltd.
  164. 4.28.1 Changde BKMAM Biotechnology Co. Ltd. Company Information
  165. 4.28.2 Changde BKMAM Biotechnology Co. Ltd. Business Overview
  166. 4.28.3 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  167. 4.28.4 Changde BKMAM Biotechnology Co. Ltd. Defibrinated Animal Blood Product Portfolio
  168. 4.28.5 Changde BKMAM Biotechnology Co. Ltd. Recent Developments
  169. 4.29 Beijing Baiao Leibo Technology Co., Ltd.
  170. 4.29.1 Beijing Baiao Leibo Technology Co., Ltd. Company Information
  171. 4.29.2 Beijing Baiao Leibo Technology Co., Ltd. Business Overview
  172. 4.29.3 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Sales, Revenue and Gross Margin (2021-2026)
  173. 4.29.4 Beijing Baiao Leibo Technology Co., Ltd. Defibrinated Animal Blood Product Portfolio
  174. 4.29.5 Beijing Baiao Leibo Technology Co., Ltd. Recent Developments
5 Global Defibrinated Animal Blood Market Scenario by Region
  1. 5.1 Global Defibrinated Animal Blood Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Defibrinated Animal Blood Sales by Region: 2021-2032
  3. 5.2.1 Global Defibrinated Animal Blood Sales by Region: 2021-2026
  4. 5.2.2 Global Defibrinated Animal Blood Sales by Region: 2027-2032
  5. 5.3 Global Defibrinated Animal Blood Revenue by Region: 2021-2032
  6. 5.3.1 Global Defibrinated Animal Blood Revenue by Region: 2021-2026
  7. 5.3.2 Global Defibrinated Animal Blood Revenue by Region: 2027-2032
  8. 5.4 North America Defibrinated Animal Blood Market Facts & Figures by Country
  9. 5.4.1 North America Defibrinated Animal Blood Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Defibrinated Animal Blood Sales by Country (2021-2032)
  11. 5.4.3 North America Defibrinated Animal Blood Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Defibrinated Animal Blood Market Facts & Figures by Country
  16. 5.5.1 Europe Defibrinated Animal Blood Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Defibrinated Animal Blood Sales by Country (2021-2032)
  18. 5.5.3 Europe Defibrinated Animal Blood Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Defibrinated Animal Blood Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Defibrinated Animal Blood Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Defibrinated Animal Blood Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Defibrinated Animal Blood Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Defibrinated Animal Blood Market Facts & Figures by Country
  41. 5.7.1 South America Defibrinated Animal Blood Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Defibrinated Animal Blood Sales by Country (2021-2032)
  43. 5.7.3 South America Defibrinated Animal Blood Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Defibrinated Animal Blood Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Defibrinated Animal Blood Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Defibrinated Animal Blood Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Defibrinated Animal Blood Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Defibrinated Animal Blood Sales by Type (2021-2032)
  2. 6.1.1 Global Defibrinated Animal Blood Sales by Type (2021-2032) & (kL)
  3. 6.1.2 Global Defibrinated Animal Blood Sales Market Share by Type (2021-2032)
  4. 6.2 Global Defibrinated Animal Blood Revenue by Type (2021-2032)
  5. 6.2.1 Global Defibrinated Animal Blood Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Defibrinated Animal Blood Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Defibrinated Animal Blood Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Defibrinated Animal Blood Sales by Application (2021-2032)
  2. 7.1.1 Global Defibrinated Animal Blood Sales by Application (2021-2032) & (kL)
  3. 7.1.2 Global Defibrinated Animal Blood Sales Market Share by Application (2021-2032)
  4. 7.2 Global Defibrinated Animal Blood Revenue by Application (2021-2032)
  5. 7.2.1 Global Defibrinated Animal Blood Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Defibrinated Animal Blood Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Defibrinated Animal Blood Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Defibrinated Animal Blood Value Chain Analysis
  2. 8.1.1 Defibrinated Animal Blood Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Defibrinated Animal Blood Production Mode & Process
  5. 8.2 Defibrinated Animal Blood Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Defibrinated Animal Blood Distributors
  8. 8.2.3 Defibrinated Animal Blood Customers
9 Global Defibrinated Animal Blood Analyzing Market Dynamics
  1. 9.1 Defibrinated Animal Blood Industry Trends
  2. 9.2 Defibrinated Animal Blood Industry Drivers
  3. 9.3 Defibrinated Animal Blood Industry Opportunities and Challenges
  4. 9.4 Defibrinated Animal Blood Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst